Biosimilar Market Size By Application, Industry Analysis Report, Regional Outlook (North America, Europe, Asia Pacific, Middle East & Africa, And South America), Growth Potential, Price Trends, Competitive Market Share & Forecast 2023 - 2030 (Recession Impact Analysis)
ID : MRU_
1816 | Date :
Jan, 2023 | Pages :
168 | Region : Global |
Publisher : 99 Strategy
A product is termed as biosimilar product, if it is a biological product with similar characteristics as that of a reference biological product, which possesses approval from agencies such as FDA. There would not be any major clinical difference in effectiveness and safety as that of reference product. Biosimilar products are made of complex molecules with high molecular weight produced through genetic engineering in living cells. Biologics drugs are costlier than respective chemical drugs. Biosimilar drugs can save around 30 to 40 % in terms of price relative to the respective biologics drugs. Biosimilars are useful for the treatment of illnesses such as anemia, autoimmune diseases, cancer, diabetes, growth hormone deficiencies, hematological diseases, kidney failure, rheumatoid arthritis and others. For the manufacturing of biosimilars, manufacturers have to develop environments that are ideal for the living cells, which remain sensitive to environmental conditions. Moreover, they need to develop distinctive process to entice the living cells for producing similar outcome to a prevalent biological treatment. The substitution of biological drugs with biosimilar drugs can save lot of money for public health care sector and patients. The regulatory authorities in developed nations are promoting biosimilar products.
The Global Biosimilar Market touched xxx million USD with a CAGR xx % from 2018-2022 around the world. In the future, it is predicted to reach xxx million USD in 2023 with a CAGR xx % from 2023-2030.
As the report focuses on global Biosimilar Market, mainly in Europe and Asia Pacific, North America, Middle East and Africa, and South America. This report segmented the Market on the basis of regions, manufacturers, applications, and type.
in addition, this report introduces Market competition situation among the vendors and company profile, besides, Market price analysis and value chain features are covered in this report.
In Market segmentation by manufacturers, the report covers the following companies-
Allergan plc
BIOCAD
Biocon
BioXpress Therapeutics
Boehringer Ingelheim
Celltrion
Coherus BioSciences
Dr. Reddy\'s Laboratories
Genor BioPharma
Intas Pharmaceuticals Limited
Novartis
Pfizer
Reliance Life Sciences
In Market segmentation by geographical regions, the report has analyzed the following regions- North America (USA, Canada and Mexico) Europe (Germany, France, UK, Russia and Italy) Asia-Pacific (China, Japan, Korea, India and Southeast Asia) South America (Brazil, Argentina, Columbia etc.) Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
In Market segmentation by types covers:
Human Growth Hormones
Monoclonal Antibodies
Insulin
Peptides
Erythropoietin
Others
In Market segmentation by applications :
Oncology
Chronic and Autoimmune Diseases
Growth Hormone Deficiency
Infectious Diseases
Others
Apart from the drivers, restraints, and opportunities, the report also offers competitive landscape, including various growth strategies adopted by profiled players for establishing significant position in the industry. The segmentation included in the comprehensive report will help respectable manufacturers to set up their processing units in the regions and increase their global presence. This would also benefit the industry and increase the company\'s product portfolio.
The research provides answers to the following key questions:
• What is the estimated growth rate and Market share and size of the Biosimilar Market for the forecast period 2023-2030?
• What are the driving forces in the Biosimilar Market for the forecast period 2023-2030?
• Who are the prominent Market players and how have they gained a competitive edge over other competitors?
• What are the Market trends influencing the progress of the Biosimilar industry worldwide?
• What are the major challenges and threats restricting the progress of the industry?
• What opportunities does the Market hold for the prominent Market players? Any special requirements about this report, please let us know and we can provide custom report.
Note – In order to provide more accurate market forecast, all our reports will be updated before delivery by considering the impact of COVID-19.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global Biosimilar Market Size Growth Rate by Type (2020-2030)
1.3.2 Human Growth Hormones
1.3.3 Monoclonal Antibodies
1.3.4 Insulin
1.3.5 Peptides
1.3.6 Erythropoietin
1.3.7 Others
1.4 Market Segment by Application
1.4.1 Global Biosimilar Market Share by Application (2020-2030)
1.4.2 Oncology
1.4.3 Chronic and Autoimmune Diseases
1.4.4 Growth Hormone Deficiency
1.4.5 Infectious Diseases
1.4.6 Others
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Biosimilar Market Size
2.1.1 Global Biosimilar Revenue 2015-2030
2.1.2 Global Biosimilar Sales 2015-2030
2.2 Biosimilar Growth Rate by Regions
2.2.1 Global Biosimilar Sales by Regions 2018 - 2022
2.2.2 Global Biosimilar Revenue by Regions 2018 - 2022
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
3 Market Share by Manufacturers
3.1 Biosimilar Sales by Manufacturers
3.1.1 Biosimilar Sales by Manufacturers 2018 - 2022
3.1.2 Biosimilar Sales Market Share by Manufacturers 2018 - 2022
3.2 Revenue by Manufacturers
3.2.1 Biosimilar Revenue by Manufacturers (2018 - 2022)
3.2.2 Biosimilar Revenue Share by Manufacturers (2018 - 2022)
3.2.3 Global Biosimilar Market Concentration Ratio (CR5 and HHI)
3.3 Biosimilar Price by Manufacturers
3.4 Key Manufacturers Biosimilar Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into Biosimilar Market
3.6 Key Manufacturers Biosimilar Product Offered
3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Sales and Revenue for Each Type
4.1.1 Human Growth Hormones Sales and Revenue (2018 - 2022)
4.1.2 Monoclonal Antibodies Sales and Revenue (2018 - 2022)
4.1.3 Insulin Sales and Revenue (2018 - 2022)
4.1.4 Peptides Sales and Revenue (2018 - 2022)
4.1.5 Erythropoietin Sales and Revenue (2018 - 2022)
4.1.6 Others Sales and Revenue (2018 - 2022)
4.2 Global Biosimilar Sales Market Share by Type
4.3 Global Biosimilar Revenue Market Share by Type
4.4 Biosimilar Price by Type
5 Market Size by Application
5.1 Overview
5.2 Global Biosimilar Sales by Application
6 United States
6.1 United States Biosimilar Breakdown Data by Company
6.2 United States Biosimilar Breakdown Data by Type
6.3 United States Biosimilar Breakdown Data by Application
7 European Union
7.1 European Union Biosimilar Breakdown Data by Company
7.2 European Union Biosimilar Breakdown Data by Type
7.3 European Union Biosimilar Breakdown Data by Application
8 China
8.1 China Biosimilar Breakdown Data by Company
8.2 China Biosimilar Breakdown Data by Type
8.3 China Biosimilar Breakdown Data by Application
9 Rest of World
9.1 Rest of World Biosimilar Breakdown Data by Company
9.2 Rest of World Biosimilar Breakdown Data by Type
9.3 Rest of World Biosimilar Breakdown Data by Application
9.4 Rest of World Biosimilar Breakdown Data by Countries
9.4.1 Rest of World Biosimilar Sales by Countries
9.4.2 Rest of World Biosimilar Revenue by Countries
9.4.3 Japan
9.4.4 Korea
9.4.5 India
9.4.6 Southeast Asia
10 Company Profiles
10.1 Allergan plc
10.1.1 Allergan plc Company Details
10.1.2 Company Description and Business Overview
10.1.3 Sales, Revenue and Market Share of Biosimilar
10.1.4 Biosimilar Product Introduction
10.1.5 Allergan plc Recent Development
10.2 BIOCAD
10.2.1 BIOCAD Company Details
10.2.2 Company Description and Business Overview
10.2.3 Sales, Revenue and Market Share of Biosimilar
10.2.4 Biosimilar Product Introduction
10.2.5 BIOCAD Recent Development
10.3 Biocon
10.3.1 Biocon Company Details
10.3.2 Company Description and Business Overview
10.3.3 Sales, Revenue and Market Share of Biosimilar
10.3.4 Biosimilar Product Introduction
10.3.5 Biocon Recent Development
10.4 BioXpress Therapeutics
10.4.1 BioXpress Therapeutics Company Details
10.4.2 Company Description and Business Overview
10.4.3 Sales, Revenue and Market Share of Biosimilar
10.4.4 Biosimilar Product Introduction
10.4.5 BioXpress Therapeutics Recent Development
10.5 Boehringer Ingelheim
10.5.1 Boehringer Ingelheim Company Details
10.5.2 Company Description and Business Overview
10.5.3 Sales, Revenue and Market Share of Biosimilar
10.5.4 Biosimilar Product Introduction
10.5.5 Boehringer Ingelheim Recent Development
10.6 Celltrion
10.6.1 Celltrion Company Details
10.6.2 Company Description and Business Overview
10.6.3 Sales, Revenue and Market Share of Biosimilar
10.6.4 Biosimilar Product Introduction
10.6.5 Celltrion Recent Development
10.7 Coherus BioSciences
10.7.1 Coherus BioSciences Company Details
10.7.2 Company Description and Business Overview
10.7.3 Sales, Revenue and Market Share of Biosimilar
10.7.4 Biosimilar Product Introduction
10.7.5 Coherus BioSciences Recent Development
10.8 Dr. Reddy\'s Laboratories
10.8.1 Dr. Reddy\'s Laboratories Company Details
10.8.2 Company Description and Business Overview
10.8.3 Sales, Revenue and Market Share of Biosimilar
10.8.4 Biosimilar Product Introduction
10.8.5 Dr. Reddy\'s Laboratories Recent Development
10.9 Genor BioPharma
10.9.1 Genor BioPharma Company Details
10.9.2 Company Description and Business Overview
10.9.3 Sales, Revenue and Market Share of Biosimilar
10.9.4 Biosimilar Product Introduction
10.9.5 Genor BioPharma Recent Development
10.10 Intas Pharmaceuticals Limited
10.10.1 Intas Pharmaceuticals Limited Company Details
10.10.2 Company Description and Business Overview
10.10.3 Sales, Revenue and Market Share of Biosimilar
10.10.4 Biosimilar Product Introduction
10.10.5 Intas Pharmaceuticals Limited Recent Development
10.11 Novartis
10.12 Pfizer
10.13 Reliance Life Sciences
11 Value Chain and Sales Channels Analysis
11.1 Value Chain Analysis
11.2 Sales Channels Analysis
11.2.1 Biosimilar Sales Channels
11.2.2 Biosimilar Distributors
11.3 Biosimilar Customers
12 Market Forecast
12.1 Global Biosimilar Sales and Revenue Forecast 2020-2030
12.2 Global Biosimilar Sales Forecast by Type
12.3 Global Biosimilar Sales Forecast by Application
12.4 Biosimilar Forecast by Regions
12.4.1 Global Biosimilar Sales Forecast by Regions 2020-2030
12.4.2 Global Biosimilar Revenue Forecast by Regions 2020-2030
12.5 United States Market Forecast
12.6 European Union Market Forecast
12.7 China Market Forecast
12.8 Rest of World
12.8.1 Japan
12.8.2 Korea
12.8.3 India
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
Research Methodology
The Market Research Update offers technology-driven solutions and its full integration in the research process to be skilled at every step. We use diverse assets to produce the best results for our clients. The success of a research project is completely reliant on the research process adopted by the company. Market Research Update assists its clients to recognize opportunities by examining the global market and offering economic insights. We are proud of our extensive coverage that encompasses the understanding of numerous major industry domains.
Market Research Update provide consistency in our research report, also we provide on the part of the analysis of forecast across a gamut of coverage geographies and coverage. The research teams carry out primary and secondary research to implement and design the data collection procedure. The research team then analyzes data about the latest trends and major issues in reference to each industry and country. This helps to determine the anticipated market-related procedures in the future. The company offers technology-driven solutions and its full incorporation in the research method to be skilled at each step.
The Company's Research Process Has the Following Advantages:
Information Procurement
The step comprises the procurement of market-related information or data via different methodologies & sources.
Information Investigation
This step comprises the mapping and investigation of all the information procured from the earlier step. It also includes the analysis of data differences observed across numerous data sources.
Highly Authentic Source
We offer highly authentic information from numerous sources. To fulfills the client’s requirement.
Market Formulation
This step entails the placement of data points at suitable market spaces in an effort to assume possible conclusions. Analyst viewpoint and subject matter specialist based examining the form of market sizing also plays an essential role in this step.
Validation & Publishing of Information
Validation is a significant step in the procedure. Validation via an intricately designed procedure assists us to conclude data-points to be used for final calculations.
We are flexible and responsive startup research firm. We adapt as your research requires change, with cost-effectiveness and highly researched report that larger companies can't match.
Information Safety
Market Research Update ensure that we deliver best reports. We care about the confidential and personal information quality, safety, of reports. We use Authorize secure payment process.
We Are Committed to Quality and Deadlines
We offer quality of reports within deadlines. We've worked hard to find the best ways to offer our customers results-oriented and process driven consulting services.
Our Remarkable Track Record
We concentrate on developing lasting and strong client relationship. At present, we hold numerous preferred relationships with industry leading firms that have relied on us constantly for their research requirements.
Best Service Assured
Buy reports from our executives that best suits your need and helps you stay ahead of the competition.
Customized Research Reports
Our research services are custom-made especially to you and your firm in order to discover practical growth recommendations and strategies. We don't stick to a one size fits all strategy. We appreciate that your business has particular research necessities.
Service Assurance
At Market Research Update, we are dedicated to offer the best probable recommendations and service to all our clients. You will be able to speak to experienced analyst who will be aware of your research requirements precisely.
